Despite Negative Reports, Robotic Surgery Remains Popular
Da Vinci surgical robotic system has invading the operating rooms in the United States. It is manufactured by Intuitive Surgical to provide robot-assisted surgery and allows the surgeon to perform complex procedures easily. The robotic tools allow the surgeon to make precise cuts and provide a better three-dimensional view than traditional surgical tools. Human surgeons direct the machines, which have been cleared for chest, cardiac, urological, and gynecological procedures. However, surgical robots have their drawbacks, just like other forms of surgeries, according to online sources.
Current robotic systems do not provide tactile or haptic feedback to the operating surgeon. Under certain circumstances, particularly with the manipulation of delicate tissues and suture materials, this may prove to be a significant irritation. Robotic surgery is also quite expensive compared to conventional laparascopic surgeries. Despite high cost, robotic surgery does not necessarily improve the patient's long-term results. There is an increasing number of adverse reports related to da Vinci that has prompted the Food and Drug Administration (FDA) to look into the problem. Patients have reported to experience problems during or after the surgery. There are 500 adverse reports related to the medical device that have been filed since January 1, 2012, according to an FDA database. References:
|